Cellectis (CLLS) Misses Q1 EPS Views

Cellectis (NASDAQ: CLLS) reported Q1 EPS of (EUR0.84), EUR0.44 worse than the analyst estimate of (EUR0.40). Revenue for the quarter came in at EUR9.5 million versus the consensus estimate of EUR10.3 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Hermès can regain momentum despite China weakness, Jefferies says